Russell Frank Company’s bluebird bio BLUE Stock Holding History

Russell Frank Company’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$203K	Sell	369 -51	-12%	-$31.3K	﹤0.01%	2668
2015 Q4	$353K	Sell	420 -115	-21%	-$115K	﹤0.01%	2571
2015 Q3	$592K	Sell	535 -721	-57%	-$1.31M	﹤0.01%	2425
2015 Q2	$2.74M	Sell	1,256 -652	-34%	-$1.33M	﹤0.01%	1800
2015 Q1	$2.99M	Sell	1,908 -1,368	-42%	-$1.8M	0.01%	1538
2014 Q4	$3.94M	Buy	3,276 +1,409	+75%	+$942K	0.01%	1439
2014 Q3	$868K	Buy	1,867 +458	+33%	+$211K	﹤0.01%	2118
2014 Q2	$704K	Buy	+1,409	New	+$452K	﹤0.01%	2207

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Russell Frank Company's BLUE Position: Q1 2016 in Review

Russell Frank Company reduced its bluebird bio (BLUE) stake by 12% in Q1 2016, selling an estimated $31.3K and leaving 369 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #2668.

Russell Frank Company first reported a position in BLUE in Q2 2014 and has held it in 8 quarters since. The position peaked at $3.94M in Q4 2014. 187 funds tracked by Wall St. Rank hold BLUE as of Q1 2016.

Russell Frank Company held 369 shares of bluebird bio worth $203K as of Q1 2016.
Russell Frank Company sold 51 bluebird bio shares in Q1 2016, an estimated $31.3K.
bluebird bio made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2668 holding.
Russell Frank Company first reported a position in bluebird bio in Q2 2014 and has held it in 8 quarters since.
Russell Frank Company's bluebird bio position peaked at $3.94M in Q4 2014.
187 funds tracked by Wall St. Rank held bluebird bio as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.